(Q35826170)

10 August 2017

Leflunomide in active rheumatoid arthritis: a prospective study in daily practice (English)

1 reference

10 August 2017

0 references

E N Van Roon

1

1 reference

10 August 2017

T L Th A Jansen

2

1 reference

10 August 2017

L Mourad

3

1 reference

10 August 2017

P M Houtman

4

1 reference

10 August 2017

G A W Bruyn

5

1 reference

10 August 2017

E N Griep

6

1 reference

10 August 2017

B Wilffert

7

1 reference

10 August 2017

H Tobi

8

1 reference

10 August 2017

J R B J Brouwers

9

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

57

1 reference

10 August 2017

6

1 reference

10 August 2017

790-797

1 reference

Rheumatoid arthritis treatment with weekly leflunomide: an open-label study.

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884519

Efficacy and safety of leflunomide and predisposing factors for treatment response in patients with active rheumatoid arthritis: RELIEF 6-month data.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884519

Leflunomide use during the first 33 months after food and drug administration approval: experience with a national cohort of 3,325 patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884519

Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884519

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884519

Leflunomide: mode of action in the treatment of rheumatoid arthritis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884519

Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884519

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884519

Why we need observational studies to evaluate the effectiveness of health care

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884519

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884519

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

11 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02075.X

A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02075.X

Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02075.X

Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02075.X

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02075.X

Synovial fluid neutrophil function in RA: the effect of pregnancy associated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02075.X

Weekly dose of leflunomide for the treatment of refractory rheumatoid arthritis: an open pilot comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02075.X

Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884519

Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884519

The rationale for combination therapy of rheumatoid arthritis based on pathophysiology

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884519

Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis

24 September 2018

1 reference

12 December 2020

Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines

1 reference

12 December 2020

Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score

1 reference

12 December 2020

Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group

1 reference

12 December 2020

Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirt

1 reference

12 December 2020

ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology

1 reference

12 December 2020

Cytokine production by synovial T cells in rheumatoid arthritis

1 reference

12 December 2020

10.1111/J.1365-2125.2004.02075.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

15151525

1 reference